European Journal of Vascular and Endovascular Surgery最新文献_第8页

Transcranial Duplex Evaluation of Internal Carotid Artery Flow Direction during Transcarotid Artery Revascularisation with Integrated Embolic Protection 综合栓塞保护下经颈动脉再灌注过程中颈内动脉血流方向的经颅双工评价。

IF 5.7 1区医学

European Journal of Vascular and Endovascular Surgery Pub Date : 2025-06-01 DOI: 10.1016/j.ejvs.2025.01.045

Alexandros Mallios , Guillaume Henry-Bonniot , Nazih Chaouch , Karim Nehme , Yann Gouëffic , Stephan Haulon

{"title":"Transcranial Duplex Evaluation of Internal Carotid Artery Flow Direction during Transcarotid Artery Revascularisation with Integrated Embolic Protection","authors":"Alexandros Mallios , Guillaume Henry-Bonniot , Nazih Chaouch , Karim Nehme , Yann Gouëffic , Stephan Haulon","doi":"10.1016/j.ejvs.2025.01.045","DOIUrl":"10.1016/j.ejvs.2025.01.045","url":null,"abstract":"<div><h3>Objective</h3><div>The aim of this study was to report the findings of transcranial duplex (TCD) evaluation of petrous internal carotid artery (ICA) flow during transcarotid artery revascularisation (TCAR). Thirty day clinical results were also evaluated.</div></div><div><h3>Methods</h3><div>A two centre database of all consecutive patients who had TCD evaluation of the petrous segment of the ICA during TCAR with a modified approach using the Neuroguard IEP (Contego Medical, Raleigh, NC, USA) three in one device and selective flow reversal was reviewed retrospectively. This novel carotid stent has an integrated embolic protection (IEP) system, and the procedure has been termed TCAR-IEP. The study primary endpoint was the achievement or not of flow reversal, and secondary endpoints were procedural technical success and 30 day stroke and or death.</div></div><div><h3>Results</h3><div>Between January and May 2023, 22 consecutive patients (mean age 72 years; 16 [73%] males) underwent TCAR-IEP with concomitant TCD evaluation of the ipsilateral petrous ICA. In 16 of these patients (73%) there was a sufficient temporal bone window to allow for an adequate peri-operative duplex scan of the petrous segment of the ICA. After common carotid artery (CCA) clamping and side port opening for pressure differential augmentation and despite the presence of retrograde flow in an 8 F carotid artery sheath in all patients, only eight patients (50%) demonstrated flow reversal in the ipsilateral petrous ICA. Technical success was 100%. No major strokes or death were observed in the first 30 days post-intervention.</div></div><div><h3>Conclusion</h3><div>In this study, distal ICA flow reversal was not present during TCAR for a significant proportion of patients despite retrograde flow being visually observed in the CCA sheath. Addition of distal embolic protection in all patients appears reasonable for effective stroke risk reduction.</div></div>","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":"69 6","pages":"Pages 807-811"},"PeriodicalIF":5.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143366826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Prospective, Multicentre Registry on Thirty Day and One Year Outcomes of the E-liac Stent Graft System in Patients with Unilateral or Bilateral Aorto-iliac or Iliac Aneurysms: The PLIANTII Study PLIANTII研究：单侧或双侧主动脉-髂或髂动脉瘤患者使用E-liac支架系统治疗30天和1年的前瞻性多中心登记

IF 5.7 1区医学

European Journal of Vascular and Endovascular Surgery Pub Date : 2025-06-01 DOI: 10.1016/j.ejvs.2025.02.029

Alexander Oberhuber , Sebastien Deglise , Olaf Richter , Vladimir Makaloski , Umberto Bracale , Giacomo Isernia , Roland Tines , Alessandro Cappelli , Bernhard Dorweiler , Jan Brunkwall

{"title":"A Prospective, Multicentre Registry on Thirty Day and One Year Outcomes of the E-liac Stent Graft System in Patients with Unilateral or Bilateral Aorto-iliac or Iliac Aneurysms: The PLIANTII Study","authors":"Alexander Oberhuber , Sebastien Deglise , Olaf Richter , Vladimir Makaloski , Umberto Bracale , Giacomo Isernia , Roland Tines , Alessandro Cappelli , Bernhard Dorweiler , Jan Brunkwall","doi":"10.1016/j.ejvs.2025.02.029","DOIUrl":"10.1016/j.ejvs.2025.02.029","url":null,"abstract":"<div><h3>Objective</h3><div>The aim of this study was to prospectively evaluate the real world outcomes of the E-liac stent graft system used to electively treat common iliac artery aneurysms, either unilaterally or bilaterally.</div></div><div><h3>Methods</h3><div>PLIANTII is a prospective, observational, non-randomised, multicentre study. The E-liac stent graft system was implanted for the treatment of iliac artery aneurysms in 295 patients across 30 European centres between September 2018 and September 2023, with 236 patients also treated for a concomitant infrarenal abdominal aortic aneurysm. The endpoints, including clinical outcomes, are reported up to the twelve month follow up. The primary endpoint was a composite of freedom from type I or III endoleak plus patency of the external (EIA) and internal iliac arteries (IIA) on the E-liac implantation side(s) at the twelve month follow up. Technical success was defined as successful access and deployment of the stent graft without surgical conversion, death, type I or III endoleak, or graft limb occlusion, assessed at discharge or 30 days. Clinical success, evaluated at twelve months, also included the absence of stent graft infection and iliac aneurysm rupture.</div></div><div><h3>Results</h3><div>Two hundred and ninetyfive consecutive patients (95.6% male; mean age 72.7 years) were included. The primary endpoint was achieved in 91.8%. No death was recorded within 30 days of implantation, and seven deaths had occurred at twelve months. The Kaplan–Meier estimated survival rate up to the twelve month follow up visit was 96.7 ± 1.2%. Technical success at discharge or 30 days was achieved in 93.1% of patients, while clinical success at twelve months was achieved in 91.2%. There were 5.4% re-interventions within 30 days and 12.9% within twelve months. The Kaplan–Meier estimated freedom from E-liac related re-intervention up to the twelve month follow up visit was 91.3 ± 1.8%. The primary patency rate at discharge or 30 day visit was 97.6% (284/291) for the EIA and 96.2% (280/291) for the IIA, whereas Kaplan–Meier estimated freedom from occlusion up to twelve months was 94.5 ± 1.6% for the EIA and 94.7 ± 1.5% for the IIA.</div></div><div><h3>Conclusion</h3><div>The one year data from the PLIANTII study show that treatment with the E-liac stent graft system is safe and results in good technical and clinical success rates.</div></div>","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":"69 6","pages":"Pages 847-854"},"PeriodicalIF":5.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143476945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

An assessment of the BEST-CLI Trial demonstrates that infrainguinal bypass offers a potential advantage in smokers with chronic limb-threatening ischemia 一项对BEST-CLI试验的评估表明，腹股沟下旁路治疗对患有慢性肢体缺血的吸烟者具有潜在的优势

IF 5.7 1区医学

European Journal of Vascular and Endovascular Surgery Pub Date : 2025-06-01 DOI: 10.1016/j.ejvs.2025.04.064

Andrew R. Barleben MD, MPH , Rohini J. Patel MD , Alik Farber , Matthew T. Menard MD , Maarit Venermo MD , Mark A. Creager , Katherine M. Reitz , Michael Strong MA , Kenneth Rosenfield MD , Gheorghe Doros PhD , Michael Dake MD , Rabih A. Chaer

引用次数: 0

Incidence of Iliac Artery Aneurysm Rupture Peri- and Post-operatively after Surgical Management of Coexisting Pelvic Malignancies: A Retrospective Study 并发盆腔恶性肿瘤手术治疗前后髂动脉瘤破裂发生率：回顾性研究。

IF 5.7 1区医学

European Journal of Vascular and Endovascular Surgery Pub Date : 2025-06-01 DOI: 10.1016/j.ejvs.2025.02.005

Hao Liu , Ke Wang , Zhaoyu Chen , Wenjiang Wei , Liheng Li , Chengjiang Xiao

引用次数: 0

One Less Step for Operators, One Giant Leap for Fenestrated Endovascular Aneurysm Repair? 操作员少走一步，带孔血管内动脉瘤修补术大跃进？

IF 5.7 1区医学

European Journal of Vascular and Endovascular Surgery Pub Date : 2025-06-01 DOI: 10.1016/j.ejvs.2025.02.007

Ryan Gouveia e Melo , Raphaël Coscas

引用次数: 0

Comparing Post-operative Anticoagulation: Rivaroxaban and Apixaban Demonstrate Similar Clot Strengths 比较术后抗凝：利伐沙班和阿哌沙班表现出相似的凝块强度。

IF 5.7 1区医学

European Journal of Vascular and Endovascular Surgery Pub Date : 2025-06-01 DOI: 10.1016/j.ejvs.2025.01.047

Aaliya Ashik , Adriana Rodriguez , Lois Owolabi , Isabella Cieri , Shiv Patel , Anahita Dua

引用次数: 0

Gender Representation among Speakers and Chairs at the European Society for Vascular Surgery Annual Meetings 在欧洲血管外科学会年会上，演讲者和主席中的性别代表。

IF 5.7 1区医学

European Journal of Vascular and Endovascular Surgery Pub Date : 2025-06-01 DOI: 10.1016/j.ejvs.2025.01.034

Jana Hammoud , Jennifer Canonge , Salomé Kuntz , Justine Mougin , Marine Bordet , Jean N. Sénémaud

引用次数: 0

Commentary on: A Systematic Review and Meta-analysis of 24 Month Patency after Endovenous Stenting of Superior Vena Cava, Subclavian, and Brachiocephalic Vein Stenosis 评论：上腔静脉、锁骨下静脉和头臂静脉狭窄静脉内支架置入术后24个月通畅的系统回顾和meta分析。

IF 5.7 1区医学

European Journal of Vascular and Endovascular Surgery Pub Date : 2025-06-01 DOI: 10.1016/j.ejvs.2024.12.042

Yi Deng , Wei Cui , Jing Li

引用次数: 0

Iatrogenic Pseudoaneurysm of the Right Dorsalis Pedis Artery 右足背动脉医源性假性动脉瘤。

IF 5.7 1区医学

European Journal of Vascular and Endovascular Surgery Pub Date : 2025-06-01 DOI: 10.1016/j.ejvs.2024.12.021

Zihan Zhang, Fei Mei

引用次数: 0

Editor's Choice – Outcomes of Single or Two Stage Brachiobasilic Arteriovenous Fistula: A Nationwide Swedish Registry Study 单期或两期肱基底动静脉瘘的结局：一项瑞典全国登记研究。

IF 5.7 1区医学

European Journal of Vascular and Endovascular Surgery Pub Date : 2025-06-01 DOI: 10.1016/j.ejvs.2024.12.027

Gunilla Welander , Fredrik Lundin , Hawshin Palanjafi , Birgitta Sigvant

{"title":"Editor's Choice – Outcomes of Single or Two Stage Brachiobasilic Arteriovenous Fistula: A Nationwide Swedish Registry Study","authors":"Gunilla Welander , Fredrik Lundin , Hawshin Palanjafi , Birgitta Sigvant","doi":"10.1016/j.ejvs.2024.12.027","DOIUrl":"10.1016/j.ejvs.2024.12.027","url":null,"abstract":"<div><h3>Objective</h3><div>Creation of a brachiobasilic arteriovenous fistula (BBAVF) can be performed as either a one or two stage procedure; however, evidence for the best technique is conflicting. The aim of this national registry review was to determine whether functional outcomes favoured either method.</div></div><div><h3>Methods</h3><div>This was a retrospective observational study with data from the Swedish Renal Registry. BBAVFs created in patients aged ≥ 18 years between 2011 and 2019 were included and were categorised as one stage (BB1) or two stage (BB2). Outcome, patency, and complications were captured from creation onwards, as were all open and endovascular repeat procedures.</div></div><div><h3>Results</h3><div>BB1s (<em>n</em> = 224) were more common than BB2s (<em>n</em> = 83). Of the BB2s, 66 (80%) were transposed in the second stage. The most common reason for not performing transposition was occlusion (<em>n</em> = 10). The median follow up was two years (interquartile range [IQR] 0.8, 4.2). Overall, 31% of BBAVFs were never used. Vein stenosis was common, seen in 157 BB1s (70%) and 40 BB2s (48%). The incidence of endovascular interventions per patient year was two times higher in BB1s than BB2s (0.6 <em>vs.</em> 0.3). Primary patency at one year was 39% and 54% in BB1 and BB2, respectively (<em>p</em> = .002). Secondary patency at one and three years was similar between groups (BB1 81% and 69%, and BB2 82% and 78%; <em>p</em> = .14). Diabetes as a comorbidity and female sex were associated with worse patency, but body mass index ≥ 30 kg/m<sup>2</sup> was not. Creation pre-dialysis did not affect patency. The median time from creation to first puncture was 73 days (IQR 51, 157) and 141 days (IQR 105, 225) for BB1 and BB2, respectively.</div></div><div><h3>Conclusion</h3><div>The two stage method had superior primary patency, counterbalanced by two operations. Long term patency was equivalent for the two surgical techniques. The incidence of endovascular re-interventions was high, and BBAVFs were less usable in females and patients with diabetes as a comorbidity.</div></div>","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":"69 6","pages":"Pages 889-896"},"PeriodicalIF":5.7,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142873566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0